Jazz Pharmaceuticals to Acquire GW Pharma

In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.

The post Jazz Pharmaceuticals to Acquire GW Pharma appeared first on Cannabis Industry Journal.

New Book On Cannabis Describes A Global Market In Transition

Marguerite Arnold’s new book about the inside story of the German cultivation bid, “Green II: Spreading Like Kudzu,” contains surprises and inside stories you have never heard before – no matter who you are in the industry. Here is an exclusive first look excerpt.

The post New Book On Cannabis Describes A Global Market In Transition appeared first on Cannabis Industry Journal.